Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mirja Ruutu

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The Journal of Urology|November 11, 2005
Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative studyJukka Sairanen, Teuvo L J Tammela, Mikael Leppilahti, et al.
Scandinavian Journal of Urology and Nephrology|January 13, 2009
Evaluation of health-related quality of life in patients with painful bladder syndrome/interstitial cystitis and the impact of four treatments on itJukka Sairanen, Mikael Leppilahti, Teuvo L J Tammela, et al.
The Lancet. Oncology|August 9, 2011
Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trialEva Johansson, Gunnar Steineck, Lars Holmberg, et al.
Journal of Medical Screening|May 4, 2011
Prostate cancer screening: a survey of attitudes and practices among Finnish physicians in 1999 and 2007Dimitri Pogodin-Hannolainen, Harri Juusela, Teuvo L J Tammela, et al.
BJU International|February 27, 2010
Why do men opt out of prostate-cancer screening? Attitudes and perception among participants and non-participants of a screening trialHanna Malmi, Mirja Ruutu, Liisa Määttänen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2003
Decreased expression of vascular endothelial growth factor in idiopathic membranous glomerulonephritis: relationships to clinical courseEero Honkanen, Eva von Willebrand, Petri Koskinen, et al.
International Journal of Cancer|May 18, 2010
Results of the three rounds of the Finnish Prostate Cancer Screening Trial--the incidence of advanced cancer is decreased by screeningTuomas P Kilpeläinen, Anssi Auvinen, Liisa Määttänen, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 7, 2012
Active surveillance for small renal tumors: have clinical concerns been addressed so far?Paolo Gontero, Steven Joniau, Marco Oderda, et al.
European Urology|November 17, 2007
Diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per literPatrik Finne, Anssi Auvinen, Liisa Määttänen, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2009
A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate cancerGreetta Joensuu, Timo Joensuu, Petri Nokisalmi, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Urology|November 11, 2005
Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative studyJukka Sairanen, Teuvo L J Tammela, Mikael Leppilahti, et al.
Scandinavian Journal of Urology and Nephrology|January 13, 2009
Evaluation of health-related quality of life in patients with painful bladder syndrome/interstitial cystitis and the impact of four treatments on itJukka Sairanen, Mikael Leppilahti, Teuvo L J Tammela, et al.
The Lancet. Oncology|August 9, 2011
Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trialEva Johansson, Gunnar Steineck, Lars Holmberg, et al.
Journal of Medical Screening|May 4, 2011
Prostate cancer screening: a survey of attitudes and practices among Finnish physicians in 1999 and 2007Dimitri Pogodin-Hannolainen, Harri Juusela, Teuvo L J Tammela, et al.
BJU International|February 27, 2010
Why do men opt out of prostate-cancer screening? Attitudes and perception among participants and non-participants of a screening trialHanna Malmi, Mirja Ruutu, Liisa Määttänen, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 5, 2003
Decreased expression of vascular endothelial growth factor in idiopathic membranous glomerulonephritis: relationships to clinical courseEero Honkanen, Eva von Willebrand, Petri Koskinen, et al.
International Journal of Cancer|May 18, 2010
Results of the three rounds of the Finnish Prostate Cancer Screening Trial--the incidence of advanced cancer is decreased by screeningTuomas P Kilpeläinen, Anssi Auvinen, Liisa Määttänen, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 7, 2012
Active surveillance for small renal tumors: have clinical concerns been addressed so far?Paolo Gontero, Steven Joniau, Marco Oderda, et al.
European Urology|November 17, 2007
Diagnostic value of free prostate-specific antigen among men with a prostate-specific antigen level of <3.0 microg per literPatrik Finne, Anssi Auvinen, Liisa Määttänen, et al.
International Journal of Radiation Oncology, Biology, Physics|December 17, 2009
A phase I/II trial of gefitinib given concurrently with radiotherapy in patients with nonmetastatic prostate cancerGreetta Joensuu, Timo Joensuu, Petri Nokisalmi, et al.
Pageof 4